Wordt geladen...
Long-Term Continuous Suppression With Once-Yearly Histrelin Subcutaneous Implants for the Treatment of Central Precocious Puberty: A Final Report of a Phase 3 Multicenter Trial
CONTEXT AND OBJECTIVE: The histrelin implant has proven to be an effective method of delivering GnRH analog (GnRHa) therapy to children with central precocious puberty (CPP), yet there are limited data available regarding hormonal suppression and auxological changes during an extended course of ther...
Bewaard in:
| Gepubliceerd in: | J Clin Endocrinol Metab |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Endocrine Society
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4504932/ https://ncbi.nlm.nih.gov/pubmed/25803268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-3031 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|